Health encyclopaedia - Alphabetical Topic List

| A | | B | | C | | D | | E | | F | | G | | H | | I | | J | | K | | L | | M |
| N | | O | | P | | Q | | R | | S | | T | | U | | V | | W | | X | | Y |

References of Alzheimer's disease

Further reading:

Ginkgo does not enhance memory. NeLH report on clinical trail.

Memory and dementia. Royal College of Psychiatrists.

Guidance on the Use of Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease. NICE.

Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease: a rapid and systematic review. Clegg A et al. Health Technology Assessment 2001, volume 5, number 1.

Dementia - diagnosis and treatment. Bandolier 1998, issue 48, page 2.

The effect of different diagnostic criteria on the prevalence of dementia. Erikinjuntti T et al. New England Journal of Medicine 1997, volume 337, pages 1667-74.

Sources of variability in prevalence rates of Alzheimer's disease. Corrada M et al. International Journal of Epidemiology 1995, volume 25, pages 1000-5.

Donepezil, Rivastigmine and Galantamine for the Treatment of Alzheimer's Disease. Technology Appraisal Guidance No 19. 2001

Galantamine for Alzheimer's disease (Cochrane Review). Olin J, Schneider L. The Cochrane Library, Issue 1, 2002.

Selegiline for Alzheimer's disease (Cochrane Review). Birks J, Flicker L. The Cochrane Library, Issue 1, 2002.

Donepezil for mild and moderate Alzheimer's disease (Cochrane Review). Birks JS et al. The Cochrane Library, Issue 1, 2002.

Rivastigmine for Alzheimer's disease (Cochrane Review). Birks J et al, The Cochrane Library, Issue 1, 2002.

Thiamine for Alzheimer's disease (Cochrane Review). Rodríguez-Martín JL et al. The Cochrane Library, Issue 1, 2002.

Physostigmine for Alzheimer's disease (Cochrane Review). Coelho Filho JM, Birks J. The Cochrane Library, Issue 1, 2002.

Efficacy and safety of Nicotine on Alzheimer's disease patients (Cochrane Review). López-Arrieta JM et al. The Cochrane Library, Issue 1, 2002.

Vitamin E for Alzheimer's disease (Cochrane Review). Tabet N et al. The Cochrane Library, Issue 1, 2002.

Statins for the prevention of Alzheimer's disease (Cochrane Review). Scott HD, Laake K. The Cochrane Library, Issue 1, 2002.

Please note that NHS Direct is not responsible for the content of external websites.